Clinical Trial: A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594522) titled 'A Study of Ivonescimab in People With Non-Small Cell Lung Cancer' on May 13.

Brief Summary: The researchers are doing this study to find out whether ivonescimab after receiving standard stereotactic body radiotherapy (SBRT) is an effective treatment in people with Non-Small Cell Lung Cancer (NSCLC).

Study Start Date: May 12

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer

Intervention: RADIATION: Photon or Proton standard stereotactic body radiotherapy (SBRT)

Radiation therapy to start within 28 days after enrollment. Radiation therapy will be performed in accordance with institutional standard practice. Proton...